Baxter International BAX Total Cost of Revenue
Total Cost of Revenue at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Baxter International in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Baxter International’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Baxter International's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Baxter International's total cost of revenue?
- Baxter International (BAX) reported total cost of revenue of $1.81B in Q1 2026.
- How has Baxter International's total cost of revenue changed year-over-year?
- Baxter International's total cost of revenue increased by 2.6% year-over-year, from $1.76B to $1.81B.
- What is the long-term trend for Baxter International's total cost of revenue?
- Over 4 years (2021 to 2025), Baxter International's total cost of revenue has grown at a 1.4% compound annual growth rate (CAGR), from $7.43B to $7.87B.
- What does total cost of revenue mean?
- The direct costs incurred to produce the goods or services sold by the company.
- How do you interpret total cost of revenue?
- An increase relative to revenue suggests rising production costs or supply chain inefficiencies, while a decrease may indicate improved manufacturing productivity.
- How does total cost of revenue compare across companies?
- Varies by industry; medical device manufacturers often have higher cost of revenue due to regulatory compliance and quality control requirements.